水友性甲福明和水性比古安化物通过不同的机制抑制线粒体复合体I
Zhaoxiang He1, Fei Teng2, Yanqing Yang3
1Department of Biophysics and Department of Critical Care Medicine of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Nature structural & molecular biology
|November 10, 2025
概括
甲胺是一种2型糖尿病药物,在打开时通过进入呼吸道复合体I并被困而起作用. 这种机制解释了它的安全性和有效性,与其他比瓜尼德不同.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲福明是一种广泛用于治疗2型糖尿病的抗高血糖药物.
- 它的安全性概况已经确立,但其精确的作用机制,特别是与疏水性比瓜尼德相比,仍然不清楚.
- 据认为,疏水性比古安化物可以很好地抑制呼吸道复合体I,但甲胺的弱弱,非竞争性抑制显而易见.
研究的目的:
- 阐明甲福明与呼吸复合体I相互作用的分子机制.
- 为美特福明的良好的药理性质和临床成功提供结构基础.
- 为了比较甲福明的结合机制与疏水性比瓜尼德的结合机制,Proguanil.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定甲胺结合的猪呼吸体 (复合I) 的结构.
- 动力测试分析结合亲和力和抑制机制.
- 整合结构和动力学数据以建模甲福林的相互作用.
主要成果:
- 甲素只在开放状态下与I复合体结合.
- 乌比金的结合会诱导一种 conformational 关闭,在乌比金的氧化还原部位上捕获甲福胺.
- 普罗瓜尼尔的结合方式不同,它既占据了入口部位,也占据了氧化还原部位,表现出具有依据形状的亲缘关系的竞争性抑制.
- 这种机制解释了甲福尔的弱弱,非竞争性抑制和积极的ubiquinone合作性.
结论:
- 这项研究为复合体I中甲福明独特的结合模式提供了分子基础.
- 这种机制是甲福明在2型糖尿病中卓越的安全性,广泛的治疗窗口和临床疗效的基础.
- 这些发现有助于理解比瓜尼德的作用以及未来药物开发的潜力.
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
568
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
568
01:30The Electron Transport Chain
19.6K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
19.6K
01:46Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
01:48ATP Synthase: Mechanism
16.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.6K
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
511
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
511
01:23Dipeptidyl Peptidase 4 Inhibitors
570
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
570